✦ LIBER ✦

Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration

✍ Scribed by Ch. Dittrich; G. Greim; M. Borner; K. Weigang-Köhler; H. Huisman; A. Amelsberg; A. Ehret; J. Wanders; A. Hanauske; P. Fumoleau

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and pharmacokinetic study of BIB

✍ Ch. Dittrich; G. Greim; M. Borner; K. Weigang-Köhler; H. Huisman; A. Amelsberg; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Phase I, pharmacokinetic (PK), and biolo

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Phase I dose-finding and pharmacokinetic

✍ Noboru Yamamoto; Atsushi Horiike; Yasuhito Fujisaka; Haruyasu Murakami; Tatsu Sh 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 367 KB

Phase I, pharmacokinetic (PK) and biolog

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Phase I and pharmacokinetic study of TSU

✍ Yutaka Ueda; Tatsu Shimoyama; Haruyasu Murakami; Noboru Yamamoto; Yasuhide Yamad 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 472 KB

552 Evaluation of the pharmacokinetic (P

✍ C. Delbaldo; J.Y. Pierga; V. Dieras; S. Faivre; M. Bonnay; J.C. Vedovato; M. Mue 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB